HIVEP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.468000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.899960E-01
Normal-vs-Stage2
2.859600E-01
Normal-vs-Stage3
6.055700E-02
Normal-vs-Stage4
7.182600E-01
Stage1-vs-Stage2
5.549600E-01
Stage1-vs-Stage3
3.419000E-01
Stage1-vs-Stage4
3.721200E-01
Stage2-vs-Stage3
1.775640E-01
Stage2-vs-Stage4
5.367800E-01
Stage3-vs-Stage4
1.435960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.957980E-01
Normal-vs-AfricanAmerican
9.532200E-01
Normal-vs-Asian
1.763830E-01
Caucasian-vs-AfricanAmerican
3.790000E-01
Caucasian-vs-Asian
3.994200E-01
AfricanAmerican-vs-Asian
1.829590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.598200E-01
Normal-vs-Female
2.482400E-01
Male-vs-Female
6.057200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.582400E-01
Normal-vs-Age(41-60Yrs)
7.028800E-01
Normal-vs-Age(61-80Yrs)
1.216590E-01
Normal-vs-Age(81-100Yrs)
8.066100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.083000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.744600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.324400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.194500E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.782900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.389200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.387000E-01
Normal-vs-Daily Drinker
3.889600E-02
Normal-vs-Weekly Drinker
3.133600E-01
Normal-vs-Occasional Drinker
5.130200E-01
Normal-vs-Social Drinker
7.047600E-01
Non Drinker-vs-Daily Drinker
3.373800E-01
Non Drinker-vs-Weekly Drinker
4.826000E-01
Non Drinker-vs-Occasional Drinker
2.815400E-01
Non Drinker-vs-Social Drinker
9.599500E-02
Daily Drinker-vs-Weekly Drinker
1.318390E-01
Daily Drinker-vs-Occasional Drinker
9.690400E-02
Daily Drinker-vs-Social Drinker
2.153900E-02
Weekly Drinker-vs-Occasional Drinker
7.483400E-01
Weekly Drinker-vs-Social Drinker
4.088600E-01
Occasional Drinker-vs-Social Drinker
6.237400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.740800E-01
Normal-vs-Grade 2
1.323360E-01
Normal-vs-Grade 3
1.097370E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.516000E-01
Grade 1-vs-Grade 3
1.925760E-01
Grade 1-vs-Grade 4
3.740800E-01
Grade 2-vs-Grade 3
2.575800E-01
Grade 2-vs-Grade 4
1.323360E-01
Grade 3-vs-Grade 4
1.097370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.656200E-01
Normal-vs-NonDiabetic
1.790620E-01
Diabetic-vs-NonDiabetic
6.687400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.172300E-02
Normal-vs-NoPancreatitis
2.203000E-01
Pancreatitis-vs-NoPancreatitis
6.309000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.878350E-01
Normal-vs-N1
2.963200E-01
N0-vs-N1
1.875640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.202000E-01
Normal-vs-TP53-NonMutant
1.910560E-01
TP53-Mutant-vs-TP53-NonMutant
7.231400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
